Cargando…
An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding
Sitosterolemia (OMIM #210250) is a rare lipid disorder caused by variants in genes encoding adenosine triphosphate (ATP)-binding cassette subfamily G Member 5 (ABCG5) or 8 (ABCG8), which play roles in the intestinal and biliary excretion of cholesterol and plant sterols, such as sitosterol and campe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068626/ https://www.ncbi.nlm.nih.gov/pubmed/37020702 http://dx.doi.org/10.1297/cpe.2022-0075 |
_version_ | 1785018700133302272 |
---|---|
author | Yoshida, Aya Aoyama, Kohei Yamaguchi, Naoya Suzuki, Atsushi Mizuno, Haruo Tada, Hayato Saitoh, Shinji |
author_facet | Yoshida, Aya Aoyama, Kohei Yamaguchi, Naoya Suzuki, Atsushi Mizuno, Haruo Tada, Hayato Saitoh, Shinji |
author_sort | Yoshida, Aya |
collection | PubMed |
description | Sitosterolemia (OMIM #210250) is a rare lipid disorder caused by variants in genes encoding adenosine triphosphate (ATP)-binding cassette subfamily G Member 5 (ABCG5) or 8 (ABCG8), which play roles in the intestinal and biliary excretion of cholesterol and plant sterols, such as sitosterol and campesterol. Although considered an autosomal recessive disorder, recent reports have shown that a heterozygous ABCG5 variant can also cause mild symptoms. Here, we report the case of an infant with a heterozygous variant of ABCG5. A 6-mo-old breast-fed Japanese male infant was found to have elevated serum total cholesterol and low-density lipoprotein-cholesterol (LDL-C) levels of 528 mg/dL and 449 mg/dL, respectively, upon examination for growth disturbances. As weaning progressed, the cholesterol levels normalized. Genetic analysis revealed that the patient and his mother had the heterozygous variant c.1166G>A (p.Arg389His) in ABCG5. Compared to his father, who did not have the ABCG5 variant, the patient and his mother had mild elevations of serum sitosterol and campesterol. Serum sitosterol and campesterol levels were 9.6 and 12 μg/mL for the patient, 4.9 and 9.3 μg/mL for his mother, and 2.1 and 3.4 μg/mL for his father, respectively. Therefore, heterozygous variants of ABCG5 may lead to transient hypercholesterolemia during breastfeeding. |
format | Online Article Text |
id | pubmed-10068626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Japanese Society for Pediatric Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-100686262023-04-04 An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding Yoshida, Aya Aoyama, Kohei Yamaguchi, Naoya Suzuki, Atsushi Mizuno, Haruo Tada, Hayato Saitoh, Shinji Clin Pediatr Endocrinol Case Report Sitosterolemia (OMIM #210250) is a rare lipid disorder caused by variants in genes encoding adenosine triphosphate (ATP)-binding cassette subfamily G Member 5 (ABCG5) or 8 (ABCG8), which play roles in the intestinal and biliary excretion of cholesterol and plant sterols, such as sitosterol and campesterol. Although considered an autosomal recessive disorder, recent reports have shown that a heterozygous ABCG5 variant can also cause mild symptoms. Here, we report the case of an infant with a heterozygous variant of ABCG5. A 6-mo-old breast-fed Japanese male infant was found to have elevated serum total cholesterol and low-density lipoprotein-cholesterol (LDL-C) levels of 528 mg/dL and 449 mg/dL, respectively, upon examination for growth disturbances. As weaning progressed, the cholesterol levels normalized. Genetic analysis revealed that the patient and his mother had the heterozygous variant c.1166G>A (p.Arg389His) in ABCG5. Compared to his father, who did not have the ABCG5 variant, the patient and his mother had mild elevations of serum sitosterol and campesterol. Serum sitosterol and campesterol levels were 9.6 and 12 μg/mL for the patient, 4.9 and 9.3 μg/mL for his mother, and 2.1 and 3.4 μg/mL for his father, respectively. Therefore, heterozygous variants of ABCG5 may lead to transient hypercholesterolemia during breastfeeding. The Japanese Society for Pediatric Endocrinology 2023-02-28 2023 /pmc/articles/PMC10068626/ /pubmed/37020702 http://dx.doi.org/10.1297/cpe.2022-0075 Text en 2023©The Japanese Society for Pediatric Endocrinology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Case Report Yoshida, Aya Aoyama, Kohei Yamaguchi, Naoya Suzuki, Atsushi Mizuno, Haruo Tada, Hayato Saitoh, Shinji An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding |
title | An infant with a heterozygous variant of ABCG5
presented with hypercholesterolemia only during breastfeeding |
title_full | An infant with a heterozygous variant of ABCG5
presented with hypercholesterolemia only during breastfeeding |
title_fullStr | An infant with a heterozygous variant of ABCG5
presented with hypercholesterolemia only during breastfeeding |
title_full_unstemmed | An infant with a heterozygous variant of ABCG5
presented with hypercholesterolemia only during breastfeeding |
title_short | An infant with a heterozygous variant of ABCG5
presented with hypercholesterolemia only during breastfeeding |
title_sort | infant with a heterozygous variant of abcg5
presented with hypercholesterolemia only during breastfeeding |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068626/ https://www.ncbi.nlm.nih.gov/pubmed/37020702 http://dx.doi.org/10.1297/cpe.2022-0075 |
work_keys_str_mv | AT yoshidaaya aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT aoyamakohei aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT yamaguchinaoya aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT suzukiatsushi aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT mizunoharuo aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT tadahayato aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT saitohshinji aninfantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT yoshidaaya infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT aoyamakohei infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT yamaguchinaoya infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT suzukiatsushi infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT mizunoharuo infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT tadahayato infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding AT saitohshinji infantwithaheterozygousvariantofabcg5presentedwithhypercholesterolemiaonlyduringbreastfeeding |